Resident
gut bacteria are important for digesting food, synthesizing nutrients, and
controlling growth of pathogenic bacteria. Alterations in the gut microbiota
can result in outgrowth of pathogenic organisms. Certain phyla of bacteria,
namely Prevotellaceae and members of the TM7 phylum, elicit inflammation and
have been associated with periodontal and inflammatory bowel disease (IBD).
This
is the basis of an article by Elana Ehrlich and the article is being hosted by
Qiagen.
Recently,
mice deficient in the protein NLRP6 were shown to have a more colitogenic
bacterial population with high representation of members of the Prevotellaceae
and TM7 phyla. This colitogenic microbiota was transferable to neonatal and
co-housed adult wild type mice. The altered microbiota stimulated CCL5
secretion which triggered chronic inflammation and increased incidence of
spontaneous and induced IBD. NLRP proteins are components of inflammasomes,
suggesting that NLRP6 inflammasomes are important for maintaining a healthy gut
microbiota. These findings have implications for development of new treatment
options for IBD. Analyzing inflammasome and related pathways such as autophagy,
ER stress and innate and adaptive immunity, through real time PCR will expand
our understanding of this process.
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources